Home » Topics » Regulatory » Patents

Patents
RSS

MedImmune reports antibodies linked to dimeric pyrrolobenzodiazepine

April 11, 2016

Shifa Biomedical reports endothelial lipase inhibitors

April 11, 2016

Merck & Co. patents prolyl hydroxylase inhibitors

April 11, 2016

Bayer Schering Pharma discloses factor XIa kallikrein B inhibitors

April 11, 2016

FORMA Therapeutics introduces isocitrate dehydrogenase inhibitors

April 8, 2016

Intra-Cellular Therapies discloses PDE1B inhibitors

April 8, 2016

Jiangsu Carefree, Nanjing Carephar and Nanjing Carephar Shenghui report JAK inhibitors

April 8, 2016

Changzhou Yinsheng Pharmaceutical and Sichuan University patent HCV NS4B inhibitors

April 8, 2016

Bayer Schering Pharma divulges factor XIa inhibitors

April 8, 2016

FORMA Therapeutics develops mutant-isocitrate dehydrogenase inhibitors

April 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...